跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 26,172 条关于
“HRD tumors”
全部
26,172
临床试验
19,565
药物
884
机构
67
资讯
5,656
去年
Eisbach Bio Relocates to Houston with $4.75M CPRIT Grant to Advance EIS-12656 Trial in HRD Tumors
去年
Niraparib Shows Promise in Extending Progression-Free Survival in Epithelial Ovarian Cancer
去年
PD-L1 Expression Correlates with HRD Status and Predicts Survival in High-Grade Serous Ovarian Cancer
去年
IDEAYA Biosciences Announces Strategic Updates and 2025 Corporate Guidance
6年前
PARP Inhibitors in Frontline Ovarian Cancer Treatment: A Review of Clinical Trials
2个月前
AI-Derived Biomarker From Routine Pathology Images Predicts Individual Benefit From PARP Inhibitors in Ovarian Cancer
去年
RNA Polymerase I Inhibitors Emerge as Promising Cancer Therapy with Pindnarulex Leading Clinical Development
8个月前
Whole-Genome Sequencing Algorithm Outperforms Standard Tests for Predicting PARP Inhibitor Response
5天前
Huons Wins Three State Drug Development Grants to Advance mRNA Eye Drop, ADC and Peptide Cancer Drug
4个月前
MammaPrint Genomic Profiling Predicts Anthracycline Benefit in HR+HER2- Early Breast Cancer, Guiding NCCN Guideline Update
第 1 页,共 566 页
上一页
下一页